Print

Novo Nordisk A/S (NVO): Reduction of the Share Capital  
4/22/2013 12:17:10 PM

BAGSVAERD, DENMARK--(Marketwired - April 22, 2013) - At Novo Nordisk's Annual General Meeting on 20 March 2013, it was decided to reduce the company's B share capital from DKK 452,512,800 to DKK 442,512,800 by cancellation of part of the company's portfolio of own B shares at a nominal value of DKK 10,000,000 divided into 10,000,000 B shares of DKK 1 each.

Articles of Association of Novo Nordisk A/S:

http://hugin.info/2013/R/1694756/557436.pdf

Company announcement No 28 / 2013:

http://hugin.info/2013/R/1694756/557435.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1694756]


Further information

Media:

Anne Margrethe Hauge
+45 4442 3450
Email Contact

Ken Inchausti (US)
+1 609 514 8316
Email Contact

Investors:

Kasper Roseeuw Poulsen
+45 4442 4303
Email Contact

Frank Daniel Mersebach
+45 4442 0604
Email Contact

Lars Borup Jacobsen
+45 3075 3479
Email Contact

Jannick Lindegaard (US)
+1 609 786 4575
Email Contact


//-->